Company profile

Ticker
BDX
Exchange
Website
CEO
Vincent A. Forlenza
Employees
Incorporated in
Location
Fiscal year end
SEC CIK
IRS number
220760120

BDX stock data

(
)

Calendar

7 May 20
2 Jul 20
30 Sep 20

News

Company financial data Financial data

Quarter (USD) Mar 20 Dec 19 Sep 19 Jun 19
Revenue 4.25B 4.23B 4.58B 4.35B
Net income 183M 278M 163M 451M
Diluted EPS 0.53 0.87 0.45 1.51
Net profit margin 4.30% 6.58% 3.56% 10.37%
Operating income 370M 501M 111M 626M
Net change in cash 1.79B 24M 13M -163M
Cash on hand 2.35B 560M 536M 523M
Cost of revenue 2.52B 2.25B 2.32B 2.28B
Annual (USD) Sep 19 Sep 18 Sep 17 Sep 16
Revenue 17.29B 15.98B 12.09B 12.48B
Net income 1.23B 311M 1.1B 976M
Diluted EPS 3.94 0.6 4.6 4.49
Net profit margin 7.13% 1.95% 9.10% 7.82%
Operating income 1.76B 1.51B 1.52B 1.43B
Net change in cash -604M -13.04B 12.64B 117M
Cash on hand 536M 1.14B 14.18B 1.54B
Cost of revenue 9B 8.71B 6.13B 6.49B

Financial data from company earnings reports

Date Owner Security Transaction Code $Price #Shares $Value #Remaining
5 Jun 20 Kaltenbach Patrick Common Stock Sell Dispose S 243.2 1,049 255.12K 11,612
3 Jun 20 Kaltenbach Patrick Common Stock Payment of exercise Dispose F 0 2,027 0 12,661
2 Jun 20 Kaltenbach Patrick Common Stock Sell Dispose S 244.83 222 54.35K 14,688
1 Jun 20 Kaltenbach Patrick Common Stock Payment of exercise Dispose F 0 400 0 14,910
27 May 20 Jones Christopher Ian Montague Rights to Common Stock Under 1996 Directors Deferral Plan Common Stock Grant Aquire A 234.59 106 24.87K 7,271
27 May 20 Scott Bertram L Rights to Common Stock Under 1996 Directors Deferral Plan Common Stock Grant Aquire A 234.59 106 24.87K 15,562
8 May 20 Fraser Claire Common Stock Sell Dispose S 256.56 771 197.81K 20,168
78.6% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 1374 1441 -4.6%
Opened positions 108 156 -30.8%
Closed positions 175 89 +96.6%
Increased positions 521 503 +3.6%
Reduced positions 542 507 +6.9%
13F shares
Current Prev Q Change
Total value 52.3B 61.95B -15.6%
Total shares 227.75M 227.65M +0.0%
Total puts 1.42M 1M +41.8%
Total calls 1.01M 758.88K +33.0%
Total put/call ratio 1.4 1.3 +6.6%
Largest owners
Shares Value Change
Vanguard 24.04M $5.52B +2.1%
N Price T Rowe Associates 21.94M $5.04B -20.8%
BLK BlackRock 19M $4.37B -0.1%
STT State Street 11.49M $2.64B +0.3%
FMR 9.11M $2.09B -32.4%
Wellington Management 8.47M $1.95B +225.4%
MS Morgan Stanley 5.9M $1.36B +1.0%
Massachusetts Financial Services 4.09M $938.97M +27.7%
Geode Capital Management 3.75M $858.92M +1.5%
JPM JPMorgan Chase & Co. 3.73M $856.77M +7.5%
Largest transactions
Shares Bought/sold Change
Wellington Management 8.47M +5.87M +225.4%
N Price T Rowe Associates 21.94M -5.78M -20.8%
FMR 9.11M -4.36M -32.4%
Parnassus Investments 2.44M +2.44M NEW
Norges Bank 0 -2.29M EXIT
Veritas Asset Management 1.49M +1.49M NEW
Flossbach Von Storch 1.88M +1.44M +334.5%
Generation Investment Management 1.72M +1.35M +365.9%
Charles Schwab Investment Management 2.45M +1.27M +108.8%
Charles Schwab Investment Advisory 0 -1.27M EXIT

Financial report summary

?
Management Discussion
  • Second quarter Medical segment revenues reflected strong growth in the Pharmaceutical Systems and Diabetes Care units that was offset by declines in the Medication Management Solutions and Medication Delivery Solutions units. As anticipated, the Medication Management Solutions unit's revenues were unfavorably impacted by the delay of shipments of AlarisTM infusion pumps, as previously discussed above. Also as expected, the Medication Delivery Solutions unit's second quarter revenues in China were unfavorably impacted by a new volume-based procurement process which has been adopted by several of China's provinces. The Medication Delivery Solutions unit's second quarter revenues also reflected an unfavorable impact relating to the COVID-19 pandemic, most notably in China, where healthcare utilization declined significantly. The Diabetes Care unit realized a benefit to second quarter revenues from COVID-19 due to increased orders from retailers and distributors in the United States.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: adhering, affirmed, agent, al, appointed, approach, avoid, bank, California, captioned, Civ, CLW, concealed, confidence, conversion, declared, deemed, degree, deploying, detect, detection, Diego, divert, effort, enabled, essential, experienced, experiencing, expertise, Fargo, flexibility, guided, heightening, inspection, Joinder, Kabak, led, lifted, light, lost, mandatory, matching, meet, merit, minimize, misleading, notably, Notice, observed, officially, opposed, outbreak, pace, pandemic, past, perspective, precautionary, preserve, promulgated, purported, recovery, rendered, resume, routine, royalty, San, scale, sector, slowdown, speed, SRC, stream, submit, sudden, supplement, thereunder, travel, undertook, unprecedented
Removed: acute, adjustment, biosurgery, constrain, divestiture, documentation, flat, generated, home, recent, refuting, stage, strength, supporting, targeted, temperature, tort, uncollectible, vascular